News Medical: Thinning brain tissue predicts dementia up to a decade before symptoms

January 24, 2024

Claudia Satizabal, PhD, population health sciences and the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, and Sudha Seshadri, MD, neurology, director, of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases and senior investigator with the Framingham Heart Study, were quoted in this article.   Read More

Neuroscience News: Brain Thinning Predicts Alzheimer’s 10 Years Before Symptoms

January 24, 2024

Claudia Satizabal, PhD, population health sciences and the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, and Sudha Seshadri, MD, neurology, director, of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases and senior investigator with the Framingham Heart Study, were quoted in this article.   Read More

ScienceDaily: Thinning of brain region may signal dementia risk 5-10 years before symptoms

January 24, 2024

Claudia Satizabal, PhD, population health sciences and the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, and Sudha Seshadri, MD, neurology, director, of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases and senior investigator with the Framingham Heart Study, were quoted in this article.   Read More

Study Finds: Brain Thinning Discovered In Scans Predicts Dementia 10 Years Early

January 24, 2024

Claudia Satizabal, PhD, population health sciences and the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, and Sudha Seshadri, MD, neurology, director, of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases and senior investigator with the Framingham Heart Study, were quoted in this article.   Read More

New Atlas: MRI ‘signature’ may reveal dementia 5-to-10 years before symptoms appear

January 24, 2024

Claudia Satizabal, PhD, population health sciences and the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, and Sudha Seshadri, MD, neurology, director, of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases and senior investigator with the Framingham Heart Study, were quoted in this article.   Read More